Leotta S, Markovic U, Duminuco A, Mule A, et al. Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study. Ann Hematol 2024 Apr 13. doi: 10.1007/s00277-024-05725.
PMID: 38609726